Chiesi Group

Chiesi Group is a global, research-driven biopharmaceutical company headquartered in Parma, Italy, with more than 90 years of experience in developing innovative health solutions. The Group employs over 7,500 people across 31 affiliates, with a commercial presence in more than 100 countries worldwide. Chiesi's mission is to improve people's quality of life while acting responsibly toward patients, society and the environment. The company focuses its innovation pipeline and portfolio on three therapeutic areas: AIR, encompassing respiratory care solutions; RARE, dedicated to treatments for patients living with rare and ultra-rare diseases; and CARE, providing specialty care and consumer-facing self-care products. To accelerate scientific and technological progress, Chiesi operates a global research and development network with seven hubs located across Europe, North America and Asia. Since 2019, Chiesi has been certified as a B Corp, and the Group has adopted the legal status of Benefit Corporation in several countries, embedding social and environmental purpose directly into its governance. For Chiesi, B Corp certification is a key part of its continuous journey of measurement, improvement and transparency, providing a framework to assess progress and drive higher stand